Crotedumab Biosimilar – Anti-GCGR mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameCrotedumab Biosimilar - Anti-GCGR mAb - Research Grade
SourceCAS 1452387-69-7
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsCrotedumab,REGN-1193,GCGR,anti-GCGR
ReferencePX-TA1415
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Crotedumab Biosimilar - Anti-GCGR mAb - Research Grade

General information on Anti-GCGR[Homo sapiens] (Crotedumab) Monoclonal Antibody

Crotedumab has been investigated for the treatment of Type 2 Diabetes Mellitus.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Crotedumab Biosimilar – Anti-GCGR mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Stable Isotope Labelled Crotedumab Biosimilar – Anti-GCGR mAb – Research Grade
SIL

Stable Isotope Labelled Crotedumab Biosimilar – Anti-GCGR mAb – Research Grade

PX-TA1415-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products